TABLE 2:

Comparison of secondary clinical outcomes in the EKOS study (all patients) versus the PROACT II study

Secondary 90-Day OutcomeEKOS StudyPROACT II Study
mRS score ≤ 1, %1426
mRS score ≤ 2, %4340
mRS score ≤ 3, %57
BI ≥ 90, %3641
BI ≥ 60, %5054
NIHSS score ≤ 1, %1418
NIHSS score ≤ 4, %50
Decrease in NIHSS score ≥ 50%, %5750
Symptomatic intracranial hemorrhage, %1410
Mortality rate, %3625
Total no. of patients14104
Average time to treatment, h5.524.70
Average time to lysis, min40NA
  • Note.—NA indicates not applicable.